Search

Your search keyword '"Lamb JA"' showing total 95 results

Search Constraints

Start Over You searched for: Author "Lamb JA" Remove constraint Author: "Lamb JA" Language english Remove constraint Language: english
95 results on '"Lamb JA"'

Search Results

1. Correlated ab initio approaches to metal-metal bonding in the tricobalt extended metal atom chains

2. The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis

3. Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders

4. Autism: in search of susceptibility genes

5. Mapping of partially overlapping de novo deletions across an autism susceptibility region (AUTS5) in two unrelated individuals affected by developmental delays with communication impairment

7. Does the pain-protective GTP cyclohydrolase haplotype significantly alter the pattern or severity of pain in humans with chronic pancreatitis?

8. Individual common variants exert weak effects on the risk for autism spectrum disorderspi

9. A genome-wide scan for common alleles affecting risk for autism

10. A genome-wide linkage and association scan reveals novel loci for autism

11. MET and autism susceptibility: family and case-control studies

12. Mapping autism risk loci using genetic linkage and chromosomal rearrangements

13. A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder

14. Discovery of new myositis genetic associations through leveraging other immune-mediated diseases.

15. Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease.

16. Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.

18. Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with "idiopathic" interstitial lung disease.

19. The clinical relevance of WDFY4 in autoimmune diseases in diverse ancestral populations.

20. Epidemiology of the idiopathic inflammatory myopathies.

21. Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies.

22. Identification of Novel Associations and Localization of Signals in Idiopathic Inflammatory Myopathies Using Genome-Wide Imputation.

23. Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study.

24. Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies.

25. Response to: 'Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future' by Wang et al .

26. 47XXY and 47XXX in Scleroderma and Myositis.

27. The Genetics of Autoimmune Myositis.

28. Contribution of Rare Genetic Variation to Disease Susceptibility in a Large Scandinavian Myositis Cohort.

29. Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis.

30. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.

31. MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies.

32. Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis.

34. Neuroprotection and vasculoprotection using genetically targeted protease-ligands.

35. Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups.

36. The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis.

37. Translational Medicine: Insights from Interdisciplinary Graduate Research Training.

38. Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer.

39. Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al .

40. Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis.

41. Risk factors and disease mechanisms in myositis.

42. Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis.

43. The EuroMyositis registry: an international collaborative tool to facilitate myositis research.

44. Patient-centred standards of care for adults with myositis.

45. Genetics in inclusion body myositis.

46. Validation of copy number variation analysis for next-generation sequencing diagnostics.

47. Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.

48. Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.

49. Molecular findings from 537 individuals with inherited retinal disease.

50. New developments in genetics of myositis.

Catalog

Books, media, physical & digital resources